Cargando…

CAR‐T therapy: Prospects in targeting cancer stem cells

Cancer stem cells (CSCs), a group of tumour cells with stem cell characteristics, have the ability of self‐renewal, multi‐lineage differentiation and tumour formation. Since CSCs are resistant to conventional radiotherapy and chemotherapy, their existence may be one of the root causes of cancer trea...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cui, Xiaoyue, Liu, Rui, Duan, Lian, Cao, Dan, Zhang, Qiaoling, Zhang, Aijie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Reviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8572776/ https://www.ncbi.nlm.nih.gov/pubmed/34585512 http://dx.doi.org/10.1111/jcmm.16939

Ejemplares similares

Cancer stem cell-targeted chimeric antigen receptor (CAR)-T cell therapy: Challenges and prospects
por: Masoumi, Javad, et al.
Publicado: (2021)

Prospects for Development of Induced Pluripotent Stem Cell-Derived CAR-Targeted Immunotherapies
por: Mazza, Roberta, et al.
Publicado: (2021)

Gene Targets of CAR-T Cell Therapy for Glioblastoma
por: Wang, Chaoqun, et al.
Publicado: (2023)

CAR-T Cell Therapy—An Overview of Targets in Gastric Cancer
por: Bębnowska, Dominika, et al.
Publicado: (2020)

Prospect of Prostate Cancer Treatment: Armed CAR-T or Combination Therapy
por: Jiang, Yao, et al.
Publicado: (2022)

CAR T Cells: Cancer Cell Surface Receptors Are the Target for Cancer Therapy
por: Shademan, Behrouz, et al.
Publicado: (2022)

Therapeutic potential of CAR-T cell-derived exosomes: a cell-free modality for targeted cancer therapy
por: Tang, Xiang-Jun, et al.
Publicado: (2015)

CAR-T Cells in the Treatment of Ovarian Cancer: A Promising Cell Therapy
por: Zhang, Xi-Wen, et al.
Publicado: (2023)

Prospective approaches to enhancing CAR T cell therapy for glioblastoma
por: Choi, Sun Il, et al.
Publicado: (2022)

CAR T-Cell Cancer Therapy Targeting Surface Cancer/Testis Antigens
por: Jakobsen, Mie K., et al.
Publicado: (2020)

c-Met specific CAR-T cells as a targeted therapy for non-small cell lung cancer cell A549
por: Min, Jingting, et al.
Publicado: (2022)

Target selection for CAR-T therapy
por: Wei, Jianshu, et al.
Publicado: (2019)

The expansion of targetable biomarkers for CAR T cell therapy
por: Townsend, Michelle H., et al.
Publicado: (2018)

Podoplanin as an Attractive Target of CAR T Cell Therapy
por: Waseda, Masazumi, et al.
Publicado: (2020)

Cardiac involvement in a patient with B-cell lymphoblastic lymphoma/acute lymphoblastic leukemia and a history of allogeneic hematopoietic stem cell transplantation and CAR T-cell therapy: A case report
por: Cao, Yigeng, et al.
Publicado: (2023)

CAR-T Cell Therapy in Cancer: Tribulations and Road Ahead
por: Zhang, Qingyang, et al.
Publicado: (2020)

LunX-CAR T Cells as a Targeted Therapy for Non-Small Cell Lung Cancer
por: Hu, Ziming, et al.
Publicado: (2020)

Biomarkers as targets for CAR-T/NK cell therapy in AML
por: Shao, Ruonan, et al.
Publicado: (2023)

Integrating CAR T-Cell Therapy and Transplantation: Comparisons of Safety and Long-Term Efficacy of Allogeneic Hematopoietic Stem Cell Transplantation After CAR T-Cell or Chemotherapy-Based Complete Remission in B-Cell Acute Lymphoblastic Leukemia
por: Zhao, Yan-Li, et al.
Publicado: (2021)

Mesothelin-targeted CAR-T cells for adoptive cell therapy of solid tumors
por: Zhang, Gui-Zhen, et al.
Publicado: (2019)

B7-H3 as a Target for CAR-T Cell Therapy in Skull Base Chordoma
por: Long, Cheng, et al.
Publicado: (2021)

A good response of refractory mantel cell lymphoma to haploidentical CAR T cell therapy after failure of autologous CAR T cell therapy
por: Li, Tongjuan, et al.
Publicado: (2019)

Targeting gastrointestinal cancers with chimeric antigen receptor (CAR)-T cell therapy
por: Staudt, Ross E, et al.
Publicado: (2022)

Targeting the extra domain A of fibronectin for cancer therapy with CAR-T cells
por: Martín-Otal, Celia, et al.
Publicado: (2022)

CAR race to cancer immunotherapy: from CAR T, CAR NK to CAR macrophage therapy
por: Pan, Kevin, et al.
Publicado: (2022)

CAR-T cell therapy for lung cancer: a promising but challenging future
por: Zhong, Shupeng, et al.
Publicado: (2020)

Progress and prospects in stem cell therapy
por: Xu, Xiu-ling, et al.
Publicado: (2013)

Targeting cancer stem cell pathways for cancer therapy
por: Yang, Liqun, et al.
Publicado: (2020)

Stressed target cancer cells drive nongenetic reprogramming of CAR T cells and tumor microenvironment, overcoming multiple obstacles of CAR T therapy for solid tumors
por: Wang, Yufeng, et al.
Publicado: (2023)

Unifying heterogeneous expression data to predict targets for CAR-T cell therapy
por: Schreiner, Patrick, et al.
Publicado: (2021)

China enters CAR-T cell therapy era
por: Cao, Xin, et al.
Publicado: (2021)

Targeting cancer stem cells for reversing therapy resistance: mechanism, signaling, and prospective agents
por: Zhou, He-Ming, et al.
Publicado: (2021)

Multi Targeted CAR-T Cell Therapies for B-Cell Malignancies
por: Shah, Nirav N., et al.
Publicado: (2019)

Intercellular Adhesion Molecule-1 as Target for CAR-T-Cell Therapy of Triple-Negative Breast Cancer
por: Wei, Heng, et al.
Publicado: (2020)

The antitumor capacity of mesothelin-CAR-T cells in targeting solid tumors in mice
por: Zhang, Qian, et al.
Publicado: (2021)

Correction: Targeting the extra domain A of fibronectin for cancer therapy with CAR-T cells
Publicado: (2022)

The Race of CAR Therapies: CAR-NK Cells for Fighting B-Cell Hematological Cancers
por: Herrera, Lara, et al.
Publicado: (2021)

CAR-T Cell Therapy
por: Ahmad, Aamir
Publicado: (2020)

Pan-Cancer Analysis Identifies Tumor Cell Surface Targets for CAR-T Cell Therapies and Antibody Drug Conjugates
por: Li, Xinhui, et al.
Publicado: (2022)

Tumor buster - where will the CAR-T cell therapy ‘missile’ go?
por: Qu, Chunrun, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_8a7bj91hi2do1m5nm8av23ge33